Alnylam Pharmaceuticals Market Sentiment

Alnylam Pharmaceuticals Inc

ALNYNASDAQ

Trade with Public

$258.00

-2.10-0.81%

In chiusura: Sep 9, 5:00 PM EST

$256.95

-1.05-0.41%

Post-mercato: 5:01 PM EST

Panoramica Notizie Previsioni utili Eventi Obiettivi di prezzo Dati finanziariSentimentAzionariato Confronta Opzioni Rapporto azionario

Alnylam Pharmaceuticals Market Sentiment

Market sentiment signals for Alnylam Pharmaceuticals (ALNY): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 4.8% short float

Options Flow▲ 0.04 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

33 analysts

Options Flow (P/C)

0.04

More calls — Bullish

2,268 calls · 102 puts

Avg Consensus PT

$419

+62.9%

Highest Price Target

$583

+126.9%

Citigroup

Lowest Price Target

$256

-0.4%

Wells Fargo

Short Interest

4.8%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 8, 2026	Jefferies	Faisal Khurshid—	+1.2%	$230 → $260	Maintained	Hold
Sep 2, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+77.1%	$455 → $455	Maintained	Buy
Aug 19, 2026	BMO Capital	David Lebowitz—	+23.8%	$318	Initiate	Outperform
Aug 14, 2026	Wells Fargo	Derek Archila—	-0.4%	$316 → $256	Maintained	Equal-Weight
Aug 4, 2026	Truist Securities	Danielle Brill—	+22.6%	$410 → $315	Maintained	Buy
Aug 4, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+77.1%	$485 → $455	Maintained	Buy
Aug 3, 2026	Raymond James	Martin Auster—	+63.5%	$420 → $420	Upgrade	Outperform→Strong Buy
Aug 3, 2026	Citigroup	Eric Joseph—	+32.3%	$380 → $340	Maintained	Buy
Aug 3, 2026	Barclays	Eliana Merle—	+75.1%	$527 → $450	Maintained	Overweight
Jul 31, 2026	JP Morgan	Jessica Fye—	+45.9%	$400 → $375	Maintained	Overweight
Jul 31, 2026	RBC Capital	Luca Issi—	+36.2%	$445 → $350	Maintained	Outperform
Jul 31, 2026	Morgan Stanley	Michael Ulz—	+16.8%	$400 → $300	Maintained	Equal-Weight
Jul 31, 2026	Oppenheimer	Kostas Biliouris—	+36.2%	$500 → $350	Maintained	Outperform
Jul 31, 2026	Wells Fargo	Derek Archila—	+23.0%	$377 → $316	Maintained	Equal-Weight
Jul 31, 2026	Stifel	Paul Matteis—	+23.8%	$444 → $318	Maintained	Buy
Jul 31, 2026	Chardan Capital	Keay Nakae—	+65.4%	$425 → $425	Maintained	Buy
Jul 30, 2026	Needham	Joseph Stringer—	+38.9%	$510 → $357	Maintained	Buy
Jul 22, 2026	JP Morgan	Jessica Fye—	+55.7%	$420 → $400	Maintained	Overweight
Jul 14, 2026	B of A Securities	Tazeen Ahmad—	+59.6%	$460 → $410	Maintained	Buy
Jul 13, 2026	Truist Securities	Danielle Brill—	+59.6%	$505 → $410	Maintained	Buy
Jul 13, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+88.8%	$470 → $485	Maintained	Buy
Jul 10, 2026	Morgan Stanley	Michael Ulz—	+55.7%	$370 → $400	Maintained	Equal-Weight
Jun 29, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+82.9%	$510 → $470	Maintained	Buy
Jun 4, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+98.5%	$510 → $510	Maintained	Buy
May 19, 2026	Citigroup	Eric Joseph—	+47.9%	$380	Initiate	Buy